Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2012
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318693 Compositions and methods for inhibiting expression of mutant EGFR gene
11/27/2012US8318690 Treatment of hemoglobin (HBF/HBG) related diseases by inhibition of natural antisense transcript to HBF/HBG
11/27/2012US8318689 SiRNA-based cancer treatment
11/27/2012US8318688 Compositions and methods for altering RNAi
11/27/2012US8318687 Recombinant adeno-associated virus vector for treatment of Alzheimer disease
11/27/2012US8318686 Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
11/27/2012US8318679 Trimerising module
11/27/2012US8318674 Local treatment of bone defects
11/27/2012US8318671 Pharmaceutical preparations comprising human proNGF
11/27/2012US8318640 Methods for selective targeting
11/27/2012US8318497 Reversible, parallel and multitask cloning method and kit
11/27/2012US8318496 Compounds and methods for improving cellular uptake of oligomeric compounds
11/27/2012US8318495 Hematopoietic progenitor cell gene transduction
11/27/2012US8318494 Genetic material and chromosomal processing and manipulation methods
11/27/2012US8318493 FRT recombination sites and methods of use
11/27/2012US8318487 Materials and methods relating to the production and maintenance of cell lines
11/27/2012US8318482 VCP-based vectors for algal cell transformation
11/27/2012US8318481 High copy number self-replicating plasmids in pseudomonas
11/27/2012US8318480 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
11/27/2012US8318474 Engineered yeast cells and uses thereof
11/27/2012US8318472 Optimized nucleic acid sequences for the expression of VB4-845
11/27/2012US8318471 Nitrilases, nucleic acids encoding them and methods for making and using them
11/27/2012US8318470 Subtilases
11/27/2012US8318463 Δ8 desaturases and their use in making polyunsaturated fatty acids
11/27/2012US8318458 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
11/27/2012US8318457 FSH producing cell clone
11/27/2012US8318454 Host, transformant and method for producing the transformant and method for producing O-glycosylated heterologous protein
11/27/2012US8318436 Use of genetically modified organisms to generate biomass degrading enzymes
11/27/2012US8318425 Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/27/2012US8318421 Hepatitis-C virus testing
11/27/2012US8318205 Polyethylene glycol/polycation block copolymers
11/27/2012US8318199 Liposome for liver-specific delivery and release of therapeutic nucleic acids or drugs
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012US8318155 Nucleic acid cleaving agent
11/27/2012US8318149 Replication competent viruses capable of silencing virus inhibitory factor expression
11/27/2012US8318148 Attenuated bacteria useful in vaccines
11/27/2012US8318137 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts
11/27/2012CA2777978A1 Dac hyp compositions and methods
11/27/2012CA2666415C Agent containing fused protein of soluble rankl with epitope tag
11/27/2012CA2658221C Anti-cd40 monoclonal antibody
11/27/2012CA2656209C Methods and devices based upon a novel form of nucleic acid duplex on a surface
11/27/2012CA2567349C Method of improving t cell receptors
11/27/2012CA2540559C Expression of biologically active polypeptides in duckweed
11/27/2012CA2521497C Modulation of cytokinin activity in plants
11/27/2012CA2516702C Modified t cell receptor linked by disulphide bond between constant domain cysteine residues
11/27/2012CA2513311C Plant transformation with in vivo assembly of a trait
11/27/2012CA2493122C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
11/27/2012CA2488404C Genes and polypeptides relating to human colon cancers
11/27/2012CA2461579C Porcine adenovirus e1 region
11/27/2012CA2452836C Meningococcus adhesins nada, app and orf 40
11/27/2012CA2452819C High throughput assay system
11/27/2012CA2449157C Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2012CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments
11/27/2012CA2422057C Dipeptidyl peptidase i crystal structure and its uses
11/27/2012CA2416545C Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
11/27/2012CA2413151C Host cells containing multiple integrating vectors
11/27/2012CA2410917C Modified xylanases exhibiting increased thermophilicity and alkalophilicity
11/27/2012CA2404857C Signal transduction stress-related proteins and methods of use in plants
11/27/2012CA2396778C Methods and kits for identifying elite event gat-zm1 in biological samples
11/27/2012CA2385763C Plant seed endosperm-specific promoter
11/27/2012CA2362448C Method for improving the agronomic and nutritional value of plants
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/22/2012WO2012158828A1 Porcine reproductive and respiratory syndrome virus resistant animals
11/22/2012WO2012158778A1 Doubly secure transgenic algae or cyanobacteria strains to prevent their establishment and spread in natural ecosystems
11/22/2012WO2012158772A1 Genetic identification of domestic cat breeds and populations
11/22/2012WO2012158757A1 Proviral plasmids for production of recombinant adeno-associated virus
11/22/2012WO2012158630A1 Sorghum maturity gene and uses thereof in modulating photoperiod sensitivity
11/22/2012WO2012158561A1 Use of zscan4 and zscan4-dependent genes for direct reprogramming of somatic cells
11/22/2012WO2012158535A1 Plant regulatory elements and uses thereof
11/22/2012WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/22/2012WO2012158296A1 Methods to increase plant productivity
11/22/2012WO2012158016A1 A method for regulating biosynthesis of monolignols
11/22/2012WO2012157831A1 Method for purifying nucleic acid at ultrahigh speed
11/22/2012WO2012157814A1 Metagenome library having alginate lyase activity and novel enzyme alydw
11/22/2012WO2012157794A1 Method for mass-producing antifreeze protein derived from polar yeast
11/22/2012WO2012157778A1 Gene identification method in fragmentome analysis and expression analysis method
11/22/2012WO2012157743A1 Retroviral vector carrying exogenous sd-sa
11/22/2012WO2012157742A1 siRNA EXPRESSION RETROVIRAL VECTOR
11/22/2012WO2012157737A1 Immunity inducing agent
11/22/2012WO2012157684A1 Method for assessing progression of clinical state of malignant neoplasm by quantitative detection of dna in blood
11/22/2012WO2012157677A1 Gene coding for enzyme that reduces position 24 of steroid skeleton
11/22/2012WO2012157672A1 Method for predicting effectiveness of angiogenesis inhibitor
11/22/2012WO2012157647A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor
11/22/2012WO2012157589A1 Cell adhesion inhibitor, cell proliferation inhibitor, and method and kit for testing cancer
11/22/2012WO2012157587A1 Anti-wrinkle agent, matrix metalloproteinase (mmp) inhibitor and/or laminin 5 production promoter, each comprising 1-piperidine propionate
11/22/2012WO2012157586A1 Polynucleated megakaryocytic cell and method for manufacturing platelets
11/22/2012WO2012157484A1 Monoclonal antibody and inspection device using same
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012157408A1 Cytotoxic t cell inducer
11/22/2012WO2012157389A1 Low-molecular-weight compound capable of regulating rac activation induced by dock-a subfamily molecule, and use thereof
11/22/2012WO2012157239A1 Chodl as tumor marker and therapeutic target for cancer
11/22/2012WO2012157237A1 Osteogenesis promoter
11/22/2012WO2012157136A1 Rrecombinant human saposin b protein containing phosphorylated glucose ring and use thereof
11/22/2012WO2012156976A1 Methods of producing artemisinin in non-host plants and vectors for use in same
11/22/2012WO2012156902A1 Nematode-resistant transgenic plants
11/22/2012WO2012156865A1 Plants having one or more enhanced yield- related traits and method for making the same
11/22/2012WO2012156839A2 New generation of splice-less lentiviral vectors for safer gene therapy applications
1 ... 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 ... 4023